Kerri Viney, MPH, PhD

Sidney Sax Research Fellow
Karolinska Institutet


Dr Kerri Viney is a post-doctoral Research Fellow at the Department of Public Health Sciences, Karolinska Institutet, working with Professor Knut Lönnroth on TB patient costs, social protection, active TB case finding and the social determinants of TB. She has come to the Karolinksa from the Research School of Population Health at Australian National University (Canberra, Australia). She has worked in national TB programmes in several settings, including in: Egypt, Uganda, Australia, the Pacific Islands, the United Kingdom, Cambodia and the Philippines.

Her TB research has focussed on the social determinants of TB including: the association between TB and diabetes, quantifying social and bio-medical risk factors for TB, active TB case finding among high risk populations, and TB patient costs. She also has a research interest in human resources for health and public health capacity building. In addition to supporting the work of the SPARKS network and ActNet (in Australia), she is currently supporting a number of countries in the Asia-Pacific region to conduct TB patient cost surveys, to support measurement of the “catastrophic costs” indicator of the End TB Strategy. She is a member of the World Health Organization’s TB patient cost survey taskforce and the Stop TB Partnership Proposal Review Committee.


Kefyalew Alene, Archie C Clements, Emma S McBryde, Ernesto Jaramillo, Knut Lönnroth, Debebe Shaweno, Amelia Gulliver, Kerri Viney. Psycho-social impact and health-related quality of life in people with multidrug-resistant tuberculosis: A systematic review and meta-analysis. Journal of Infection: Available online:

Debora Pedrazzoli, Andrew Siroka, Kerri Viney, Jo Borghi, Ines Garcia Baena, Knut Lönnroth. Measuring affordability of tuberculosis care and financial protection in the End Strategy era: a review of key concepts and their application in surveys of costs faced by TB patients and their households. International Journal of Tuberculosis and Lung Disease (in press).

Claudia C Dobler, Greg J Fox, Paul Douglas, Kerri A Viney, Faiz Ahmad Khan, Zelalem Temesgen, Ben J Marais. Screening for tuberculosis in migrants and visitors from high incidence settings: present and future perspectives. European Respiratory Journal. 2018. Published ahead of print 2018, doi:10.1183/13993003.00591-2018

Alene KA, Viney K, Yi H, McBryde ES, Yang K, Bai L, Gray DJ, Xu Z, Clements ACA. Comparison of the validity of smear and culture conversion as a prognostic marker of treatment outcome in patients with multidrug-resistant tuberculosis from Hunan Chest Hospital, China and Gondar University Hospital, Ethiopia. PLoS One. 2018. 13(5): e0197880.

Alene KA, Clements ACA, McBryde ES, Jaramillo E, Lonnroth K, Saweno D, Viney K. Sequelae of multidrug resistant tuberculosis: protocol for a systematic review and meta-analysis. BMJ Open 2018; 8: e019593. doi: 10.1136/bmjopen-2017-019593

Syed Mustafa Ali; Farah Naureen; Arif Noor; Irum Fatima; Kerri Viney; Muhammad Ishaq; Naveed Anjum; Aamna Rashid; Ghulam Rasool Haider; Muhammad Aamir Khan; Javariya Aamir. Loss-to-follow-up and delay to treatment initiation in Pakistan’s National Tuberculosis Control Programme. BMC Public Health. 2018. 18:335.

Alene K, Yi H, Viney K, McBryde ES, Yang K, Bai L, Gray DJ Clements AC, Xu Z. Treatment outcomes of patients with multidrug-resistant and extensively drug resistant tuberculosis in Hunan Province, China. BMC Infectious Diseases. 2017; 17(1):573. DOI 10.1186/s12879-017-2662-8.

Research keywords: public health, global health, tuberculosis, patient costs, social determinants


Updated by:

Webmaster 2018-09-12